Athira Pharma, Inc. (ATHA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 32.37M |
| Enterprise Value | -36.11M |
| P/E Ratio | -0.22 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.91 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.49 |
| Return On Equity | -4.12 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -68.09M |
| EBITDA | 643,000 |
| Net Income | -105.61M |
| Diluted EPS | -24.7 |
Balance Sheet
| Total Cash | 51.07M |
| Total Cash/Share | 11.94 |
| Total Debt | 577,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 7.01 |
| Book Value Per Share | 7.86 |
Price History
| 52-Week Change | 53.06 |
| 52-Week High | 8.36 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 5.48 |
| Moving Average 200 Days | 4.03 |
Statistics
| Average Volume | 1.06M |
| Shares Outstanding | 3.94M |
| % Held by Institutions | 32.61 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 18, 2025 |
AD
